The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Novartis; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Ipsen; Pfizer
 
Consulting or Advisory Role - Bristol-Myers Squibb; EUSA Pharma; Merck Sharp & Dohme; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; EUSA Pharma; Ipsen; Merck Sharp & Dohme; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Calithera Biosciences (I); Ipsen (I); Merck Sharp & Dohme (I); Pfizer (I)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; EUSA Pharma
A non-interventional retrospective study to describe early clinical experience with cabozantinib in patients with advanced renal cell carcinoma (aRCC) in the United Kingdom.
 
Manon Pillai
No Relationships to Disclose
 
Thomas Powles
Honoraria - AstraZeneca; Bristol-Myers Squibb; Ferring; Gerson Lehrman Group; Janssen Research & Development; MERCK; Novartis; Pfizer; Roche/Genentech; Seattle Genetics/Astellas
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Incyte; Ipsen; Merck; Novartis; Novartis; Pfizer; Seagen
Research Funding - AstraZeneca/MedImmune; Roche/Genentech
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Ferring; MSD; Novartis/Ipsen; Pfizer; Research to Practice; Roche/Genentech
 
Bernadett Szabados
Honoraria - Merck
Travel, Accommodations, Expenses - Roche/Genentech
 
Philip Savage
Stock and Other Ownership Interests - Ipsen
Consulting or Advisory Role - Ipsen; Pfizer; Roche
 
Kate Fife
Employment - Mundipharma Research (I)
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pfizer
Consulting or Advisory Role - Eisai; Ipsen; Merck; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); Merck (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Novartis/Ipsen
 
Bhupinder Klair
Employment - Ipsen
Stock and Other Ownership Interests - Abbvie; Allogene Therapeutics; Axovant Sciences; Bristol-Myers Squibb; Calithera Biosciences; Celgene; Exelixis; Galapagos NV; Gilead Sciences; Ipsen; Johnson & Johnson; Merck; Moderna Therapeutics; Novartis
 
Valérie Perrot
Employment - Ipsen
Stock and Other Ownership Interests - Ipsen
 
Agnieszka Michael
Consulting or Advisory Role - Clovis Oncology; EUSA Pharma; Pfizer
Travel, Accommodations, Expenses - EUSA Pharma; Ipsen
 
Balaji Venugopal
No Relationships to Disclose